Heron Therapeuti Stock Net Income
| HRTX Stock | USD 2.80 0.21 8.11% |
Heron Therapeuti fundamentals help investors to digest information that contributes to Heron Therapeuti's financial success or failures. It also enables traders to predict the movement of Heron Stock. The fundamental analysis module provides a way to measure Heron Therapeuti's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Heron Therapeuti stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | -110.6 M | -105 M | |
| Net Loss | -163.8 M | -172 M | |
| Net Loss | -119.7 M | -125.7 M | |
| Net Loss | (0.80) | (0.84) | |
| Net Income Per E B T | 0.85 | 0.92 |
Heron | Net Income |
Heron Therapeuti Company Net Income Analysis
Heron Therapeuti's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Heron Therapeuti Net Income | (110.56 M) |
Most of Heron Therapeuti's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Heron Therapeuti is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Heron Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Heron Therapeuti is extremely important. It helps to project a fair market value of Heron Stock properly, considering its historical fundamentals such as Net Income. Since Heron Therapeuti's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Heron Therapeuti's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Heron Therapeuti's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Heron Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Heron Therapeuti reported net income of (110.56 Million). This is 132.4% lower than that of the Biotechnology sector and 257.84% lower than that of the Health Care industry. The net income for all United States stocks is 119.36% higher than that of the company.
Heron Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heron Therapeuti's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heron Therapeuti could also be used in its relative valuation, which is a method of valuing Heron Therapeuti by comparing valuation metrics of similar companies.Heron Therapeuti is currently under evaluation in net income category among related companies.
Heron Therapeuti Institutional Holders
Institutional Holdings refers to the ownership stake in Heron Therapeuti that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Heron Therapeuti's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Heron Therapeuti's value.| Shares | State Street Corporation | 2023-12-31 | 2.5 M | Jw Asset Management, Llc | 2023-12-31 | 2.3 M | Orchard Capital Management, Llc | 2023-12-31 | 2.2 M | Monaco Asset Management | 2023-12-31 | 2.2 M | Goldman Sachs Group Inc | 2023-12-31 | 2 M | Renaissance Technologies Corp | 2023-12-31 | 1.9 M | Tang Capital Management Llc | 2023-09-30 | 1.9 M | Congress Park Capital Llc | 2023-12-31 | 1.8 M | Millennium Management Llc | 2023-12-31 | 1.2 M | Rubric Capital Management Lp | 2023-12-31 | 26.7 M | Vanguard Group Inc | 2023-12-31 | 8.3 M |
Heron Fundamentals
| Return On Equity | -24.09 | ||||
| Return On Asset | -0.25 | ||||
| Profit Margin | (0.87) % | ||||
| Operating Margin | (0.28) % | ||||
| Current Valuation | 488.57 M | ||||
| Shares Outstanding | 150.33 M | ||||
| Shares Owned By Insiders | 0.94 % | ||||
| Shares Owned By Institutions | 76.02 % | ||||
| Number Of Shares Shorted | 25.55 M | ||||
| Price To Earning | (5.15) X | ||||
| Price To Book | 12.60 X | ||||
| Price To Sales | 3.44 X | ||||
| Revenue | 127.04 M | ||||
| Gross Profit | (50.51 M) | ||||
| EBITDA | (107.72 M) | ||||
| Net Income | (110.56 M) | ||||
| Cash And Equivalents | 83.54 M | ||||
| Cash Per Share | 0.81 X | ||||
| Total Debt | 179.63 M | ||||
| Debt To Equity | 6.64 % | ||||
| Current Ratio | 1.77 X | ||||
| Book Value Per Share | (0.23) X | ||||
| Cash Flow From Operations | (58.79 M) | ||||
| Short Ratio | 9.17 X | ||||
| Earnings Per Share | (0.80) X | ||||
| Price To Earnings To Growth | (0.18) X | ||||
| Target Price | 7.0 | ||||
| Number Of Employees | 126 | ||||
| Beta | 1.71 | ||||
| Market Capitalization | 389.35 M | ||||
| Total Asset | 222.51 M | ||||
| Retained Earnings | (1.91 B) | ||||
| Working Capital | 109.09 M | ||||
| Current Asset | 134.75 M | ||||
| Current Liabilities | 19.73 M | ||||
| Net Asset | 222.51 M |
About Heron Therapeuti Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Heron Therapeuti's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heron Therapeuti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heron Therapeuti based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Heron Therapeuti Piotroski F Score and Heron Therapeuti Altman Z Score analysis. For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Heron Stock analysis
When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
Is Heron Therapeuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heron Therapeuti. If investors know Heron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Heron Therapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Revenue Per Share 0.92 | Quarterly Revenue Growth 0.14 | Return On Assets (0.25) | Return On Equity (24.09) |
The market value of Heron Therapeuti is measured differently than its book value, which is the value of Heron that is recorded on the company's balance sheet. Investors also form their own opinion of Heron Therapeuti's value that differs from its market value or its book value, called intrinsic value, which is Heron Therapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heron Therapeuti's market value can be influenced by many factors that don't directly affect Heron Therapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heron Therapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heron Therapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heron Therapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.